Michael Wiederhorn
Stock Analyst at Oppenheimer
(4.74)
# 681
Out of 4,966 analysts
1096
Total ratings
58.5%
Success rate
10.9%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCSG Healthcare Services Group | Initiated Coverage: Buy | $28 | $21.99 | +27.33% | 1 | Aug 19, 2026 | |
| PACS PACS Group | Reiterated: Buy | $48 → $57 | $44.76 | +27.35% | 6 | Aug 10, 2026 | |
| EVH Evolent Health | Rated: Buy | $6 | $4.15 | +44.75% | 13 | Aug 7, 2026 | |
| GRDN Guardian Pharmacy Services | Reiterated: Buy | $43 → $49 | $43.41 | +12.88% | 8 | Aug 7, 2026 | |
| TDOC Teladoc Health | Rated: Buy | $7 | $6.16 | +13.64% | 31 | Aug 4, 2026 | |
| CHE Chemed | Rated: Buy | $500 → $590 | $515.97 | +14.35% | 118 | Jul 31, 2026 | |
| HUM Humana | Rated: Buy | $260 → $405 | $403.47 | +0.38% | 80 | Jul 30, 2026 | |
| ENSG The Ensign Group | Reiterated: Buy | $210 | $173.98 | +20.70% | 88 | Jul 28, 2026 | |
| HCA HCA Healthcare | Reiterated: Buy | $520 → $485 | $426.94 | +13.60% | 96 | Jul 27, 2026 | |
| CYH Community Health Systems | Reiterated: Buy | $4 | $2.89 | +38.65% | 121 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $405 → $500 | $379.09 | +31.89% | 88 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $39.37 | +1.60% | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $118.23 | +31.11% | 113 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $58 | $66.42 | -12.68% | 163 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 | $280.76 | +30.00% | 74 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $94.66 | n/a | 17 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.0001 | n/a | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $42.34 | n/a | 1 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $418.72 | n/a | 48 | Jun 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $0.04 | n/a | 6 | Aug 19, 2014 |
Healthcare Services Group
Aug 19, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $21.99
Upside: +27.33%
PACS Group
Aug 10, 2026
Reiterated: Buy
Price Target: $48 → $57
Current: $44.76
Upside: +27.35%
Evolent Health
Aug 7, 2026
Rated: Buy
Price Target: $6
Current: $4.15
Upside: +44.75%
Guardian Pharmacy Services
Aug 7, 2026
Reiterated: Buy
Price Target: $43 → $49
Current: $43.41
Upside: +12.88%
Teladoc Health
Aug 4, 2026
Rated: Buy
Price Target: $7
Current: $6.16
Upside: +13.64%
Chemed
Jul 31, 2026
Rated: Buy
Price Target: $500 → $590
Current: $515.97
Upside: +14.35%
Humana
Jul 30, 2026
Rated: Buy
Price Target: $260 → $405
Current: $403.47
Upside: +0.38%
The Ensign Group
Jul 28, 2026
Reiterated: Buy
Price Target: $210
Current: $173.98
Upside: +20.70%
HCA Healthcare
Jul 27, 2026
Reiterated: Buy
Price Target: $520 → $485
Current: $426.94
Upside: +13.60%
Community Health Systems
Jul 24, 2026
Reiterated: Buy
Price Target: $4
Current: $2.89
Upside: +38.65%
Jul 17, 2026
Rated: Buy
Price Target: $405 → $500
Current: $379.09
Upside: +31.89%
May 8, 2026
Reiterated: Buy
Price Target: $40
Current: $39.37
Upside: +1.60%
May 6, 2026
Rated: Buy
Price Target: $155
Current: $118.23
Upside: +31.11%
Apr 29, 2026
Rated: Buy
Price Target: $45 → $58
Current: $66.42
Upside: -12.68%
Oct 31, 2025
Reiterated: Buy
Price Target: $365
Current: $280.76
Upside: +30.00%
Aug 9, 2024
Reiterated: Hold
Price Target: n/a
Current: $94.66
Upside: n/a
Mar 2, 2023
Reiterated: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
Feb 9, 2018
Reiterated: Buy
Price Target: $35
Current: $42.34
Upside: n/a
Jun 7, 2017
Rated: Hold
Price Target: n/a
Current: $418.72
Upside: n/a
Aug 19, 2014
Rated: Buy
Price Target: $7
Current: $0.04
Upside: n/a